Tumor‐Targeted Drug and CpG Delivery System for Phototherapy and Docetaxel‐Enhanced Immunotherapy with Polarization toward M1‐Type Macrophages on Triple Negative Breast Cancers
出版年份 2019 全文链接
标题
Tumor‐Targeted Drug and CpG Delivery System for Phototherapy and Docetaxel‐Enhanced Immunotherapy with Polarization toward M1‐Type Macrophages on Triple Negative Breast Cancers
作者
关键词
-
出版物
ADVANCED MATERIALS
Volume 31, Issue 52, Pages 1904997
出版商
Wiley
发表日期
2019-11-13
DOI
10.1002/adma.201904997
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- “Minimalist” Nanovaccine Constituted from Near Whole Antigen for Cancer Immunotherapy
- (2018) Kun Wang et al. ACS Nano
- Tumor-targeting CuS nanoparticles for multimodal imaging and guided photothermal therapy of lymph node metastasis
- (2018) Hua Shi et al. Acta Biomaterialia
- Nanoparticle-mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy
- (2018) Xiaopin Duan et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- DNA decorated Cu9S5 nanoparticles as NIR light responsive drug carriers for tumor chemo–phototherapy
- (2018) Shuang Liang et al. DALTON TRANSACTIONS
- Docetaxel promotes the generation of anti-tumorigenic human macrophages
- (2018) Camilla Rydberg Millrud et al. EXPERIMENTAL CELL RESEARCH
- Low-dose X-ray radiotherapy–radiodynamic therapy via nanoscale metal–organic frameworks enhances checkpoint blockade immunotherapy
- (2018) Kuangda Lu et al. Nature Biomedical Engineering
- CuS@MOF-Based Well-Designed Quercetin Delivery System for Chemo–Photothermal Therapy
- (2018) Wei Jiang et al. ACS Applied Materials & Interfaces
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- An “all-in-one” antitumor and anti-recurrence/metastasis nanomedicine with multi-drug co-loading and burst drug release for multi-modality therapy
- (2018) Ji-Chun Yang et al. Chemical Science
- Myeloid‐derived suppressor cells and tumor: Current knowledge and future perspectives
- (2018) Elahe Safari et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
- (2017) Achim Rittmeyer et al. LANCET
- A retrospective examination of the US Food and Drug Administration’s clinical pharmacology reviews of oncology biologics for potential use of therapeutic drug monitoring
- (2017) Brett Fleisher et al. OncoTargets and Therapy
- PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
- (2017) Hashem O. Alsaab et al. Frontiers in Pharmacology
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
- (2016) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- Multifunctional Conjugated Polymer Nanoparticles for Image-Guided Photodynamic and Photothermal Therapy
- (2016) Guangxue Feng et al. Small
- Tumor control with PD-1 inhibition in a patient with concurrent metastatic melanoma and renal cell carcinoma
- (2016) Melina E. Marmarelis et al. Journal for ImmunoTherapy of Cancer
- Bismuth Sulfide Nanorods as a Precision Nanomedicine for in Vivo Multimodal Imaging-Guided Photothermal Therapy of Tumor
- (2015) Jing Liu et al. ACS Nano
- Nanoparticles in Photodynamic Therapy
- (2015) Sasidharan Swarnalatha Lucky et al. CHEMICAL REVIEWS
- Re: Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
- (2015) Timothy J. Daskivich et al. EUROPEAN UROLOGY
- Cancer-fighting viruses win approval
- (2015) Heidi Ledford NATURE
- Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies
- (2015) F. Hossain et al. Cancer Immunology Research
- Simultaneous Photodynamic and Photothermal Therapy Using Photosensitizer-Functionalized Pd Nanosheets by Single Continuous Wave Laser
- (2014) Zengxia Zhao et al. ACS Applied Materials & Interfaces
- Doxorubicin-Loaded Magnetic Silk Fibroin Nanoparticles for Targeted Therapy of Multidrug-Resistant Cancer
- (2014) Ye Tian et al. ADVANCED MATERIALS
- Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients
- (2014) H. R. Ali et al. ANNALS OF ONCOLOGY
- Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities
- (2013) Ameya R. Kirtane et al. ADVANCED DRUG DELIVERY REVIEWS
- Antitumor Effect of Paclitaxel Is Mediated by Inhibition of Myeloid-Derived Suppressor Cells and Chronic Inflammation in the Spontaneous Melanoma Model
- (2013) A. Sevko et al. JOURNAL OF IMMUNOLOGY
- Stimuli-responsive nanocarriers for drug delivery
- (2013) Simona Mura et al. NATURE MATERIALS
- Immunotherapeutic approaches in triple-negative breast cancer: latest research and clinical prospects
- (2013) John Stagg et al. Therapeutic Advances in Medical Oncology
- Macrophage plasticity and polarization: in vivo veritas
- (2012) Antonio Sica et al. JOURNAL OF CLINICAL INVESTIGATION
- Myeloid-Derived Suppressor Cell Inhibition of the IFN Response in Tumor-Bearing Mice
- (2011) B. L. Mundy-Bosse et al. CANCER RESEARCH
- Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice
- (2011) W. Joost Lesterhuis et al. JOURNAL OF CLINICAL INVESTIGATION
- Topoisomerase inhibitors modulate expression of melanocytic antigens and enhance T cell recognition of tumor cells
- (2010) Timothy J. Haggerty et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity
- (2010) J. Vincent et al. CANCER RESEARCH
- A Novel Chemoimmunomodulating Property of Docetaxel: Suppression of Myeloid-Derived Suppressor Cells in Tumor Bearers
- (2010) K. N. Kodumudi et al. CLINICAL CANCER RESEARCH
- Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists
- (2009) Jörg Vollmer et al. ADVANCED DRUG DELIVERY REVIEWS
- Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses
- (2009) W M Liu et al. BRITISH JOURNAL OF CANCER
- CCL2 is induced by chemotherapy and protects prostate cancer cells from docetaxel-induced cytotoxicity
- (2009) David Z. Qian et al. PROSTATE
- Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics
- (2008) Naoki Umemura et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Toll-like receptor 9 (TLR9) agonists in the treatment of cancer
- (2008) A M Krieg ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search